In this video we discuss promising results of the anti–PD-L1 agent avelumab in patients with metastatic Merkel cell carcinoma who had previously been treated with chemotherapy.
Howard L. Kaufman, MD
Advertisement
Articles by Howard L. Kaufman, MD
Advertisement
Latest Updated Articles
Avelumab Produces Durable Responses in Metastatic Merkel Cell CarcinomaPublished: June 22nd 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
What Were The Most Impactful GU Oncology Data From ESMO 2025?
4
Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma
5
